Her work focuses on brain-based measures of social attention and perception that can be used to predict risk for autism, course of symptoms, and response to treatment. Her current projects include a multisite study of gender differences in children with autism and a multisite study to develop biomarkers for clinical trials in autism. Her recent publications have focused on early infant risk markers, using brain functioning and behavior to better understand the pre-symptomatic markers of autism.